+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hepatitis Viruses Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020

  • PDF Icon

    Report

  • 86 Pages
  • November 2020
  • Region: Global
  • GlobalData
  • ID: 5212340
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Summary

The publisher's Medical Devices sector report, “Hepatitis Viruses Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Hepatitis Viruses Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hepatitis Viruses Rapid Tests & POC comprises of rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for Hepatitis B and C.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Hepatitis Viruses Rapid Tests & POC under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hepatitis Viruses Rapid Tests & POC and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hepatitis Viruses Rapid Tests & POC under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Hepatitis Viruses Rapid Tests & POC Overview
3 Products under Development
3.1 Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Stage of Development
3.2 Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Territory
3.3 Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Regulatory Path
3.4 Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Estimated Approval Date
4 Hepatitis Viruses Rapid Tests & POC - Pipeline Products under Development by Companies
4.1 Hepatitis Viruses Rapid Tests & POC Companies - Pipeline Products by Stage of Development
4.2 Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Stage of Development
5 Hepatitis Viruses Rapid Tests & POC Companies and Product Overview
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer
List of Tables
Table 1: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Stage of Development
Table 2: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Territory
Table 3: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Regulatory Path
Table 4: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Estimated Approval Date
Table 5: Hepatitis Viruses Rapid Tests & POC Companies - Pipeline Products by Stage of Development
Table 6: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Stage of Development
Table 7: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 8: Point-Of-Care Test - Hepatitis C Virus RNA Detection - Product Status
Table 9: Point-Of-Care Test - Hepatitis C Virus RNA Detection - Product Description
Table 10: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 11: PIFA Hep B / Hep C - Product Status
Table 12: PIFA Hep B / Hep C - Product Description
Table 13: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 14: Alere q Analyzer - HCV VL Assay - Product Status
Table 15: Alere q Analyzer - HCV VL Assay - Product Description
Table 16: Arkray Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Rapid Immunoassay - HCV - Product Status
Table 18: Rapid Immunoassay - HCV - Product Description
Table 19: Atomo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 20: AtomoRapid - Hepatitis C - Product Status
Table 21: AtomoRapid - Hepatitis C - Product Description
Table 22: Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Idylla Viral Load Assay - HBV - Product Status
Table 24: Idylla Viral Load Assay - HBV - Product Description
Table 25: Idylla Viral Load Assay - HCV - Product Status
Table 26: Idylla Viral Load Assay - HCV - Product Description
Table 27: bioLytical Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: INSTI Test - Hepatitis C - Product Status
Table 29: INSTI Test - Hepatitis C - Product Description
Table 30: Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Spinit Device - Hepatitis C Biomarker Assay - Product Status
Table 32: Spinit Device - Hepatitis C Biomarker Assay - Product Description
Table 33: Biotech Consortium India Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Diagnostic Kit - Hepatitis A - Product Status
Table 35: Diagnostic Kit - Hepatitis A - Product Description
Table 36: Biotech Resources Aust Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 37: ATR-FTIR System - Hepatitis B & C - Product Status
Table 38: ATR-FTIR System - Hepatitis B & C - Product Description
Table 39: Blink AG Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Point-Of-Care Test - Hepatitis C Virus RNA Detection - Product Status
Table 41: Point-Of-Care Test - Hepatitis C Virus RNA Detection - Product Description
Table 42: Boston University Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Paper Based Test - HBV - Product Status
Table 44: Paper Based Test - HBV - Product Description
Table 45: Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: GeneXpert Omni - HCV Viral Load - Product Status
Table 47: GeneXpert Omni - HCV Viral Load - Product Description
Table 48: Chembio Diagnostic Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 49: DPP Hepatitis C Virus Assay - Product Status
Table 50: DPP Hepatitis C Virus Assay - Product Description
Table 51: Next Generation DPP HCV Assay - Product Status
Table 52: Next Generation DPP HCV Assay - Product Description
Table 53: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Diagnostic Assay - Hepatitis C - Product Status
List of Figures
Figure 1: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Stage of Development
Figure 2: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Territory
Figure 3: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Regulatory Path
Figure 4: Hepatitis Viruses Rapid Tests & POC - Pipeline Products by Estimated Approval Date

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Diagnostics
  • Akers Biosciences Inc
  • Alere Inc
  • Arkray Inc
  • Atomo Diagnostics Ltd
  • Biocartis Group NV
  • bioLytical Laboratories Inc
  • Biosurfit, SA
  • Biotech Consortium India Ltd
  • Biotech Resources Aust Pty Ltd
  • Blink AG
  • Boston University
  • Cepheid Inc
  • Chembio Diagnostic Systems Inc
  • ChipCare Corp
  • Correlia Biosystems, Inc.
  • CoSara Diagnostics Pvt Ltd
  • Daktari Diagnostics, Inc.
  • DCN Diagnostics
  • Diagnostics For All Inc
  • Diagnostics for the Real World Ltd
  • Fast Track Diagnostics Ltd
  • Group K Diagnostics
  • ImmunoScience Inc
  • MedMira Inc
  • Micronics Inc
  • Mologic Ltd
  • NanoComposix Inc
  • NanoRepro AG
  • NOWDiagnostics Inc
  • Quidel Corp
  • SLS Cell Cure Technologies Pty Ltd
  • University of California Irvine
  • Wave 80 Biosciences Inc
  • Xagenic Inc

Related Topics

Related Reports

The Global Market for Medical Devices, 13th Edition - Product Image

The Global Market for Medical Devices, 13th Edition

  • Report
  • 312 Pages
  • Global
From
Global Point of Care Diagnostics Market with Focus on Asia-Pacific: Insights & Forecast with Potential Impact of COVID-19 (2023-2027) - Product Image

Global Point of Care Diagnostics Market with Focus on Asia-Pacific: Insights & Forecast with Potential Impact of COVID-19 (2023-2027)

  • Report
  • 85 Pages
  • Asia Pacific, Global Asia Pacific, Global
From
Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027 - Product Image

Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027

  • Report
  • 416 Pages
  • Global
From
Hepatitis Viruses Rapid Test Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Hepatitis Viruses Rapid Test Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 73 Pages
  • Global
From
Cardiac Markers Rapid Tests and POC Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies - Product Image

Cardiac Markers Rapid Tests and POC Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • Report
  • 50 Pages
  • Global
From
Copyright © 2002-2023 Research and Markets. All Rights Reserved.